Marianne E. Greene

1.9k total citations · 1 hit paper
20 papers, 1.3k citations indexed

About

Marianne E. Greene is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Marianne E. Greene has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in Marianne E. Greene's work include Estrogen and related hormone effects (7 papers), Advanced Breast Cancer Therapies (5 papers) and Acute Myeloid Leukemia Research (4 papers). Marianne E. Greene is often cited by papers focused on Estrogen and related hormone effects (7 papers), Advanced Breast Cancer Therapies (5 papers) and Acute Myeloid Leukemia Research (4 papers). Marianne E. Greene collaborates with scholars based in United States and Australia. Marianne E. Greene's co-authors include John D. Crispino, Judith E. Karp, Joshua B. Wechsler, Michael A. McDevitt, John Anastasi, Michelle M. Le Beau, R.J. Arceci, Gina Mundschau, Sandeep Gurbuxani and Alan S. Gamis and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Marianne E. Greene

20 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome

2002 518 citations Joshua B. Wechsler, Marianne E. Greene et al. Nature Genetics profile →

Peers

Countries citing papers authored by Marianne E. Greene

Since Specialization

Citations

This map shows the geographic impact of Marianne E. Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marianne E. Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marianne E. Greene more than expected).

Fields of papers citing papers by Marianne E. Greene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marianne E. Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marianne E. Greene. The network helps show where Marianne E. Greene may publish in the future.

Co-authorship network of co-authors of Marianne E. Greene

This figure shows the co-authorship network connecting the top 25 collaborators of Marianne E. Greene. A scholar is included among the top collaborators of Marianne E. Greene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marianne E. Greene. Marianne E. Greene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancer 2024 ·Breast Cancer Research ·(unknown), Marianne E. Greene, (unknown), Grazyna Bozek, (unknown), (unknown), Barry S. Komm, Geoffrey L. Greene	3
2	Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer 2021 ·Breast Cancer Research ·Muriel Lainé, Sean W. Fanning, Ya-Fang Chang, (unknown), Marianne E. Greene, Barry S. Komm, (unknown), (unknown), Geoffrey L. Greene	51
3	Abstract PD7-09: Lasofoxifene decreases breast cancer lung and liver metastasis in a mammary intraductal (MIND) xenograft model of mutant ERα+ breast cancer 2019 ·Cancer Research ·Minna Laine, Marianne E. Greene, (unknown), (unknown), Richard A. Hiipakka, Barry S. Komm, GL Greene	1
4	Lasofoxifene as a potential treatment for ER+ metastatic breast cancer. 2019 ·Journal of Clinical Oncology ·Muriel Lainé, Sean W. Fanning, Marianne E. Greene, Ya-Fang Chang, (unknown), (unknown), Richard A. Hiipakka, Barry S. Komm, Geoffrey L. Greene	7
5	Lasofoxifene efficacy in a mammary intraductal (MIND) xenograft model of ERα+ breast cancer. 2018 ·Journal of Clinical Oncology ·Muriel Lainé, Marianne E. Greene, Ya-Fang Chang, (unknown), Richard A. Hiipakka, Barry S. Komm, Geoffrey L. Greene	1
6	Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling 2017 ·Oncotarget ·Hari Singhal, Marianne E. Greene, (unknown), Muriel Lainé, Rose Al Abosy, Ya-Fang Chang, (unknown), Kelly Q. Schoenfelt, Raga Vadhi, Xintao Qiu, Prakash K. Rao, Bindu Santhamma, Hareesh B. Nair, Klaus Nickisch, Henry W. Long, Lev Becker, Myles Brown, Geoffrey L. Greene	50
7	Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer 2016 ·Science Advances ·Hari Singhal, Marianne E. Greene, Gerard A. Tarulli, (unknown), (unknown), Muriel Lainé, Ya-Fang Chang, Shihong Ma, (unknown), Ganesh V. Raj, Theresa E. Hickey, Wayne D. Tilley, Geoffrey L. Greene	105
8	Biochemistry and therapeutic implications of mechanisms involved in FOXP3 activity in immune suppression 2007 ·Current Opinion in Immunology ·Bofeng Li, Sandra J. Saouaf, Arabinda Samanta, Yuan Shen, Wayne W. Hancock, Marianne E. Greene	24
9	Histone deacetylase inhibitors and transplantation 2007 ·Current Opinion in Immunology ·Ran Tao, Edwin F. de Zoeten, Engin Özkaynak, Lu Wang, Bofeng Li, Marianne E. Greene, Andrew D. Wells, Wayne W. Hancock	31
10	Identification of midkine as a mediator for intercellular transfer of drug resistance 2005 ·Oncogene ·Bernard L. Mirkin, Sandra Clark, Xin Zheng, Fei Chu, (unknown), Marianne E. Greene, Abdelhadi Rebbaa	59
11	Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome 2003 ·Blood Cells Molecules and Diseases ·Marianne E. Greene, Gina Mundschau, Joshua B. Wechsler, Michael A. McDevitt, Alan S. Gamis, Judith E. Karp, Sandeep Gurbuxani, R.J. Arceci, John D. Crispino	45
12	Bcl-xL and Akt cooperate to promote leukemogenesis in vivo 2003 ·Oncogene ·(unknown), Qun Niu, (unknown), David R. Plas, Marianne E. Greene, John D. Crispino, Charles M. Rudin	29
13	Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis 2003 ·Blood ·Gina Mundschau, Sandeep Gurbuxani, Alan S. Gamis, Marianne E. Greene, R.J. Arceci, John D. Crispino	152
14	Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome breakdown → 2002 ·Nature Genetics ·Joshua B. Wechsler, Marianne E. Greene, Michael A. McDevitt, John Anastasi, Judith E. Karp, Michelle M. Le Beau, John D. Crispino	518
15	Peroxisome Proliferator-Activated Receptors and Skin Development 2000 ·Hormone Research in Paediatrics ·Robert L. Rosenfield, Dianne Deplewski, Marianne E. Greene	54
16	Flow Cytometric Immunophenotypic Characterization of Pediatric and Adult Minimally Differentiated Acute Myeloid Leukemia (AML-M0) 2000 ·American Journal of Clinical Pathology ·Patricia K. Kotylo, (unknown), Franklin O. Smith, Nyla A. Heerema, Naomi S. Fineberg, Kathy D. Miller, Marianne E. Greene, Pauline M. Chou, Attilio Orazi	26
17	Indeterminate‐cell histiocytosis: Immunophenotypic and cytogenetic findings in an infant 1999 ·Medical and Pediatric Oncology ·(unknown), Frank González-Crussí, Marianne E. Greene, Maya Thangavelu, Morris Kletzel, Pauline M. Chou	31
18	Isolation and Cloning of Human Peroxisome Proliferator Activated Receptor Gamma CDNA 1997 ·Advances in experimental medicine and biology ·Marianne E. Greene, Bruce Blumberg, Karen Kwan, Ling‐Ling Hsieh, Geoffrey L. Greene, Stephen D. Nimer	4
19	Histiocytic Necrotizing Lymphadenitis With Autoimmune Phenomena and Meningitis in a 14-Year-Old Girl 1996 ·PEDIATRICS ·Jason S. Debley, David J. Rozansky, Michael L. Miller, Ben Z. Katz, Marianne E. Greene	21
20	The Ligand-Binding Domains of the Thyroid Hormone/Retinoid Receptor Gene Subfamily Function in Vivo To Mediate Heterodimerization, Gene Silencing, and Transactivation 1995 ·Molecular and Cellular Biology ·Jian-Shen Qi, Vandana Desai-Yajnik, Marianne E. Greene, Bruce M. Raaka, Herbert H. Samuels	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact